- FDA Authorizes First Robotically-Assisted Surgical Device for Performing Transvaginal Hysterectomy
admin Tue, 03/02/2021 - 16:04
The U.S. Food and Drug Administration has authorized marketing of the Hominis Surgical System, a new robotically-assisted surgical device (RASD) that can help facilitate transvaginal hysterectomy in certain patients. The Hominis Surgical System is intended for benign hysterectomy (removal of the uterus for non-cancerous conditions) with salpingo-oophorectomy (removal of one or both fallopian tubes and ovaries).
- Atherosclerosis can accelerate the development of clonal hematopoiesis : Study
admin Mon, 03/01/2021 - 15:53
Billions of peripheral white blood cells are produced every day by the regular divisions of hematopoietic stem cells and their descendants in the bone marrow. Under normal circumstances, thousands of stem cells contribute progeny to the blood at any given time, making white blood cells a group with diverse ancestry.
- AI based system predicts the onset of Alzheimer's Disease
admin Mon, 03/01/2021 - 15:42
Korea Brain Research Institute (KBRI, President Suh Pann-ghill) announced that the research team led by Dr. Jae-Yeol Joo discovered new cryptic splice variants and SNVs in PLCg1 gene of AD-specific models for the first time using Splice-AI.
This research outcome was published in PNAS, a world-renowned academic journal.
- Cancer cells waste so much energy, Why?
admin Mon, 03/01/2021 - 15:36
In the 1920s, German chemist Otto Warburg discovered that cancer cells don’t metabolize sugar the same way that healthy cells usually do. Since then, scientists have tried to figure out why cancer cells use this alternative pathway, which is much less efficient.
- Johnson and Johnson Covid-19 Vaccine receives FDA Nod for Emergency Use
admin Mon, 03/01/2021 - 15:19
Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older.
- Catalent to Acquire Delphi Genetics
admin Fri, 02/26/2021 - 15:49
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics.
- Olympus may acquire Israeli Medical Device Company Medi-Tate
admin Fri, 02/26/2021 - 15:39
Olympus made its initial investment in Medi-Tate in November 2018, under an agreement that included the rights to distribute Medi-Tate products and gave Olympus an option to acquire 100% of the Israeli company at a later date. Medi-Tate is a medical device manufacturer engaged in the research and development, production, and sale of devices for the minimally invasive treatment of benign prostatic hyperplasia (“BPH”). The company’s flagship product “iTind” has received a European CE mark and is FDA cleared for use in the U.S.
- ‘Crowd and Mask’ Monitoring System to prevent COVID-19
admin Fri, 02/26/2021 - 15:02
Innovators at Indian Institute of Science Education and Research (IISER), Bhopal have developed a unique ‘Crowd and Mask’ Monitoring System to prevent COVID-19 from spread. This one-of-its-kind low cost Artificial Intelligence (AI)-enabled device is portable and easy to deploy across various locations, says a statement released by the institution.
- Novel technique may help in early detection of Cancer, Alzheimer’s, and Parkinson’s
admin Fri, 02/26/2021 - 14:55
Scientists from Raman Research Institute (RRI) have developed a new technique to measure DNA modifications that can have applications in the early diagnosis of multiple diseases like Cancer, Alzheimer’s, and Parkinson’s diseases.
- Medtronic Launches TYRX™ Envelope in India
admin Thu, 02/25/2021 - 15:13
India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc announced the launch of the TYRX™ Absorbable Antibacterial Envelope (TYRX Envelope) - an absorbable, single-use, antibacterial envelope designed to stabilize a cardiac implantable electronic device (CIED) or implanted neurostimulator while releasing antimicrobial agents over a minimum of seven days.